AMETEK, Inc. (NYSE:AME) Stock Position Raised by Banco Santander S.A.

Key Points

• Banco Santander S.A. increased its position in AMETEK, Inc. by 20.8%, holding 45,365 shares worth approximately $7.8 million after acquiring additional shares in Q1.
• AMETEK reported earnings of $1.78 per share, surpassing analysts' expectations, with a net margin of 20.60% and revenue of $1.78 billion for the quarter.
• Multiple hedge funds significantly raised their stakes in AMETEK, with Capital World Investors increasing its position by 70.0% and GAMMA Investing by an impressive 18,368.3%.

Banco Santander S.A. lifted its position in AMETEK, Inc. (NYSE:AME - Free Report) by 20.8% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 45,365 shares of the technology company's stock after acquiring an additional 7,799 shares during the quarter. Banco Santander S.A.'s holdings in AMETEK were worth $7,809,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in AME. Capital World Investors lifted its position in AMETEK by 70.0% in the 4th quarter. Capital World Investors now owns 5,760,017 shares of the technology company's stock worth $1,038,301,000 after buying an additional 2,371,062 shares in the last quarter. Lazard Asset Management LLC lifted its position in AMETEK by 393.1% in the 4th quarter. Lazard Asset Management LLC now owns 1,215,087 shares of the technology company's stock worth $219,030,000 after buying an additional 968,661 shares in the last quarter. GAMMA Investing LLC lifted its position in AMETEK by 18,368.3% in the 1st quarter. GAMMA Investing LLC now owns 973,280 shares of the technology company's stock worth $167,540,000 after buying an additional 968,010 shares in the last quarter. Compagnie Lombard Odier SCmA purchased a new stake in AMETEK in the 1st quarter worth approximately $113,317,000. Finally, Alteri Wealth LLC purchased a new stake in AMETEK in the 4th quarter worth approximately $114,769,000. Hedge funds and other institutional investors own 87.43% of the company's stock.

AMETEK Stock Down 1.4%

AMETEK stock opened at $182.18 on Friday. AMETEK, Inc. has a 1-year low of $145.02 and a 1-year high of $198.33. The firm's fifty day simple moving average is $179.44 and its 200-day simple moving average is $176.99. The company has a current ratio of 1.63, a quick ratio of 0.86 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $42.06 billion, a P/E ratio of 29.34, a P/E/G ratio of 2.73 and a beta of 1.10.

AMETEK (NYSE:AME - Get Free Report) last posted its earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.69 by $0.09. AMETEK had a net margin of 20.60% and a return on equity of 16.53%. The business had revenue of $1.78 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period last year, the business posted $1.66 EPS. AMETEK's revenue was up 2.5% compared to the same quarter last year. Sell-side analysts forecast that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.

AMETEK Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Friday, June 13th were paid a $0.31 dividend. The ex-dividend date was Friday, June 13th. This represents a $1.24 dividend on an annualized basis and a yield of 0.7%. AMETEK's dividend payout ratio (DPR) is presently 20.29%.

Analyst Ratings Changes

A number of research firms have issued reports on AME. Truist Financial increased their target price on shares of AMETEK from $196.00 to $200.00 and gave the stock a "buy" rating in a research report on Monday, May 5th. Royal Bank Of Canada increased their target price on shares of AMETEK from $209.00 to $212.00 and gave the stock an "outperform" rating in a research report on Friday. DA Davidson increased their target price on shares of AMETEK from $210.00 to $215.00 and gave the stock a "buy" rating in a research report on Friday. Melius downgraded shares of AMETEK from a "buy" rating to a "hold" rating and set a $192.00 target price for the company. in a research report on Monday, July 14th. Finally, Robert W. Baird cut their target price on shares of AMETEK from $197.00 to $190.00 and set a "neutral" rating for the company in a research report on Wednesday, May 7th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $200.18.

AMETEK Company Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.